ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
5.97
+0.07 (1.19%)
Jan 31, 2025, 4:00 PM EST - Market closed
ABIVAX Société Anonyme Employees
ABIVAX Société Anonyme had 61 employees as of December 31, 2023. The number of employees increased by 37 or 154.17% compared to the previous year.
Employees
61
Change (1Y)
37
Growth (1Y)
154.17%
Revenue / Employee
$158,630
Profits / Employee
-$3,116,475
Market Cap
397.73M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
ABVX News
- 4 days ago - Abivax Publishes 2025 Financial Calendar - GlobeNewsWire
- 8 days ago - Abivax Announces Presentation of Seven Abstracts for Obefazimod in Ulcerative Colitis at 2025 European Crohn's and Colitis Organization 20th Annual Congress - GlobeNewsWire
- 23 days ago - Abivax Achieves Key Milestone in Phase 3 ABTECT Trial Enrollment - GlobeNewsWire
- 5 weeks ago - Abivax Announces a Change to the Composition of its Board of Directors - GlobeNewsWire
- 2 months ago - Abivax Establishes an At-the-Market (ATM) Program on Nasdaq - GlobeNewsWire
- 2 months ago - Abivax presents third quarter 2024 key financial information - GlobeNewsWire
- 2 months ago - Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax - GlobeNewsWire
- 4 months ago - Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation - GlobeNewsWire